155 related articles for article (PubMed ID: 3014666)
1. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE
Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666
[No Abstract] [Full Text] [Related]
2. Immunohistopathology of lymph nodes in HTLV-III infected homosexuals with persistent adenopathy or AIDS.
Biberfeld P; Porwit-Ksiazek A; Böttiger B; Morfeldt-Månsson L; Biberfeld G
Cancer Res; 1985 Sep; 45(9 Suppl):4665s-4670s. PubMed ID: 2410110
[TBL] [Abstract][Full Text] [Related]
3. Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston.
Groopman JE; Mayer KH; Sarngadharan MG; Ayotte D; Devico AL; Finberg R; Sliski AH; Allan JD; Gallo RC
Ann Intern Med; 1985 Mar; 102(3):334-7. PubMed ID: 2982305
[TBL] [Abstract][Full Text] [Related]
4. Diversity of clinical spectrum of HTLV-III infection.
Valle SL; Saxinger C; Ranki A; Antonen J; Suni J; Lähdevirta J; Krohn K
Lancet; 1985 Feb; 1(8424):301-4. PubMed ID: 2857362
[TBL] [Abstract][Full Text] [Related]
5. Human T-lymphotropic retrovirus type III (HTLV-III) in Danish homosexuals.
Lange Wantzin G; Saxinger WC; Weismann K; Gallo RC
Acta Derm Venereol; 1985; 65(3):247-50. PubMed ID: 2411083
[TBL] [Abstract][Full Text] [Related]
6. Development and early natural history of HTLV-III antibodies in persons with hemophilia.
Eyster ME; Goedert JJ; Sarngadharan MG; Weiss SH; Gallo RC; Blattner WA
JAMA; 1985 Apr; 253(15):2219-23. PubMed ID: 2983132
[TBL] [Abstract][Full Text] [Related]
7. Acute encephalopathy coincident with seroconversion for anti-HTLV-III.
Carne CA; Tedder RS; Smith A; Sutherland S; Elkington SG; Daly HM; Preston FE; Craske J
Lancet; 1985 Nov; 2(8466):1206-8. PubMed ID: 2866290
[TBL] [Abstract][Full Text] [Related]
8. [Adult T-cell leukemia and human T-cell leukemia virus associated diseases in Kochi Prefecture].
Taguchi H
Rinsho Ketsueki; 1986 May; 27(5):664-9. PubMed ID: 2875203
[No Abstract] [Full Text] [Related]
9. Immune impairments and antibodies to HTLVIII/LAV in asymptomatic male homosexuals in Israel: relevance to the risk of acquired immune deficiency syndrome (AIDS).
Bentwich Z; Saxinger C; Ben-Ishay Z; Burstein R; Berner Y; Pecht M; Trainin N; Levin S; Handzel ZT
J Clin Immunol; 1987 Sep; 7(5):376-80. PubMed ID: 2443528
[TBL] [Abstract][Full Text] [Related]
10. Rising prevalence of human T-lymphotropic virus type III (HTLV-III) infection in homosexual men in London.
Carne CA; Weller IV; Sutherland S; Cheingsong-Popov R; Ferns RB; Williams P; Mindel A; Tedder R; Adler MW
Lancet; 1985 Jun; 1(8440):1261-2. PubMed ID: 2860454
[TBL] [Abstract][Full Text] [Related]
11. Subunit vaccines against exogenous retroviruses: overview and perspectives.
Hunsmann G
Cancer Res; 1985 Sep; 45(9 Suppl):4691s-4693s. PubMed ID: 2410114
[TBL] [Abstract][Full Text] [Related]
12. IgG-antibodies to HTLV-III in patients with AIDS, LAS, and persons at risk of AIDS in West Germany.
Hehlmann R; Kreeb G; Erfle V; Piechowiak H; Krüger G; Goebel FD
Blut; 1985 Jan; 50(1):13-8. PubMed ID: 2981593
[TBL] [Abstract][Full Text] [Related]
13. [Antibodies against HTLV I in T-lymphoproliferative diseases of the skin].
von der Helm D; von der Helm K; Burg G; Braun-Falco O; Deinhardt F
Hautarzt; 1988 Jun; 39(6):348-50. PubMed ID: 2841258
[TBL] [Abstract][Full Text] [Related]
14. Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24.
Casey JM; Kim Y; Andersen PR; Watson KF; Fox JL; Devare SG
J Virol; 1985 Aug; 55(2):417-23. PubMed ID: 2410630
[TBL] [Abstract][Full Text] [Related]
15. [Human T-lymphotropic retrovirus and AIDS. HTLV-III is probably the cause of acquired immunodeficiency syndrome].
Dobloug JH
Tidsskr Nor Laegeforen; 1985 Jan; 105(1):50-2. PubMed ID: 2982219
[No Abstract] [Full Text] [Related]
16. Prospects for treatment of human retrovirus-associated diseases.
Bolognesi DP; Fischinger PJ
Cancer Res; 1985 Sep; 45(9 Suppl):4700s-4705s. PubMed ID: 2410116
[TBL] [Abstract][Full Text] [Related]
17. Detection of human T-cell lymphotropic virus type III-related antigens and anti-human T-cell lymphotropic virus type III antibodies by anticomplementary immunofluorescence.
Blumberg RS; Sandstrom EG; Paradis TJ; Neumeyer DN; Sarngadharan MG; Hartshorn KL; Byington RE; Hirsch MS; Schooley RT
J Clin Microbiol; 1986 Jun; 23(6):1072-7. PubMed ID: 2423552
[TBL] [Abstract][Full Text] [Related]
18. An overview of the HTLV Symposium and reflections about the past, present, and future.
Gross L
Cancer Res; 1985 Sep; 45(9 Suppl):4706s-4709s. PubMed ID: 2861897
[No Abstract] [Full Text] [Related]
19. Seroprevalence of human T-cell lymphotropic virus type 1 among homosexual men in the United States.
Manns A; Obrams I; Detels R; Diwan A; Ginzburg HM; Goedert JJ; Blattner WA
N Engl J Med; 1988 Aug; 319(8):516-7. PubMed ID: 2900465
[No Abstract] [Full Text] [Related]
20. Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein.
Wang JJ; Steel S; Wisniewolski R; Wang CY
Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6159-63. PubMed ID: 2426711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
